New anti-ALS drug receives Orphan Drug designation
A new gene therapy for treating an inherited form of Amyotrophic Lateral Sclerosis has been given an Orphan Drug designation by the European Medicines Agency. The therapy is already in preclinical development at EPFL.
May 23, 2018
0
84